Skip to main content

StemPoint Capital LP

SEC CIK
0001952142
Latest filing
Aug 14, 2026

IMVT holding history

Immunovant, Inc. in every 13F filed by StemPoint Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IMVT overviewAll 13F holders of IMVTFull Q2 2026 holdings

Shares (Q2 2026)
276,527
Value
$10.7M
% of portfolio
1.8%
Quarters held
11
Since Q4 2023
Holdings of IMVT by StemPoint Capital LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026276,527$10.7M1.8%−469,967−63.0%ReducedHolders
Q1 2026746,494$18.5M3.6%+101,535+15.7%AddedHolders
Q4 2025644,959$16.4M2.8%−944,621−59.4%ReducedHolders
Q3 20251,589,580$25.6M5.2%+288,720+22.2%AddedHolders
Q2 20251,300,860$20.8M6.7%+447,388+52.4%AddedHolders
Q1 2025853,472$14.6M4.7%−265,036−23.7%ReducedHolders
Q4 20241,118,508$27.7M6.9%+447,507+66.7%AddedHolders
Q3 2024671,001$19.1M5.7%−340,878−33.7%ReducedHolders
Q2 20241,011,879$26.7M7.9%+384,651+61.3%AddedHolders
Q1 2024627,228$20.3M5.4%+305,213+94.8%AddedHolders
Q4 2023322,015$13.6M3.7%–No prior filingHolders